Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

lymphoma drug

- PMLiVE

New arrivals join BioHub at AZ’s Alderley Park

Six new biopharma start-ups set up at the UK biocluster

- PMLiVE

Bioclusters benefit from pharma shake-up

Sweeping job cuts at Europe’s largest drugmakers in recent years have spread gloom through the pharma sector, but the release of talent is helping to drive the development of bioclusters

- PMLiVE

Amgen and Onyx agree $10.4bn takeover deal

Deal provides indication of the premium big biopharma will pay to replenish pipelines

- PMLiVE

AZ adds to pipeline again with Amplimmune buy

Pharma company pays $500m via its MedImmune subsidiary for the small US biotech

Biotech threatened by UK drug pricing changes, says BIA

It says VBP will undermine the attractiveness of the sector for investors

- PMLiVE

Fresenius sells biotech business

Germany company's biotechnology arm picked up by Neopharm owners

- PMLiVE

Partial victory for biotech sector after gene patent ruling

US Supreme Court decides genes can be patented, if synthetically produced

Verastem promotes Robert Forrester to CEO

Takes over from Christoph Westphal who moves to executive chairman

Amgen and Novartis partner with biotech venture capital firm

Atlas Venture fund aims to create 15 new biotech companies

- PMLiVE

Biotechs urged to focus on value

Simply creating a drug that works may not be enough warns new report

- PMLiVE

UK biotech gains further £47.2m from Biomedical Catalyst funding

Programme aims to help bridge the 'valley of death' funding gap

Interview: Steve Bates, BIA

The CEO of the BioIndustry Association discusses the state of UK biotech, its shared ecosystem with pharma and the funding challenges biotech faces

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links